Resistant dermatomyositis complicated by tubercular myositis and successfully treated with rituximab

Sir, B-cell depleting monoclonal antibody rituximab (RTX) has been shown to be effective in patients with refractory dermatomyositis (DM). Magnetic resonance imaging (MRI) of the left leg revealed acute myositis and subcutaneous fluid collection in the areas mentioned [Figure 1]. B-cell driven respo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neurology India 2011-03, Vol.59 (2), p.306
Hauptverfasser:	Jois, Ramesh, Vasudevan, Nikhila, Srinivasan, Pradeep, Mehta, Ravindra
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Monoclonal, Murine-Derived - therapeutic use Care and treatment Case studies Complications and side effects Dermatomyositis Dermatomyositis - complications Dermatomyositis - therapy Diagnosis Drug therapy Female Humans Immunotherapy Medical treatment Patient outcomes Risk factors Rituximab Treatment Outcome Tuberculosis Tuberculosis - complications Tuberculosis - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!